Joe Wiley

18 results

Photograph: iStock

Biopharmaceutical firm Amryt said it had a strong year in 2017 as revenue rose to almost €13 million. The company, which focuses on rare and orphan (...)

The company is focused on rare and orphan diseases.

Irish biopharmaceutical firm Amryt Pharma has signed a new distribution agreement, its fifth in recent months. The company, which is focused on rare (...)

Photograph: iStock

Irish biopharmaceutical firm Amryt has signed a new distribution agreement, its fourth in recent months. The company, whcih focuses on rare diseases(...)

Amryt Pharma focuses on rare and orphan diseases.

Irish biopharmaceutical firm Amryt Pharma has announced the appointment of Derval O’Carroll as head of regulatory affairs. Dr Joe Wiley, chief execut(...)

Photograph: iStock

Irish biopharmaceutical firm Amryt Pharma has signed an agreement to distribute its Lojuxta drug in Switzerland. The company, which focuses on rare (...)

Amryt Pharma chief executive Joe Wiley said the company was at “exciting phase” in terms of treatments

Biopharmaceutical company Amryt Pharma is seeking to raise €15 million to fund clinical trials for the treatment of a rare, genetic skin disorder. Th(...)

Amryt Pharma has reported a sharp rise in sales for the six months to the end of June as the company became a commercial pharmaceutical business. Photograph: Getty

Amryt Pharma has reported a sharp rise in sales for the six months to the end of June, as the company became a commercial pharmaceutical group. Sales(...)

Amryt has started a phase three trial for a potential treatment for a rare genetic skin  disorder. Photograph: iStock

Amryt Pharma, the orphan drug development company that was subject to a reverse takeover of former oil and gas group Fastnet last year, posted €1.35 m(...)

  • « First
  • Prev
  • 1
  • 2